Cellular and extracellular matrix of bone, with principles of synthesis and dependency of mineral deposition on cell membrane transport

PH Schlesinger, HC Blair… - … of Physiology-Cell …, 2020 - journals.physiology.org
Bone differs from other connective tissues; it is isolated by a layer of osteoblasts that are
connected by tight and gap junctions. This allows bone to create dense lamellar type I …

Chemotherapeutic agents in noncytotoxic concentrations increase antigen presentation by dendritic cells via an IL-12-dependent mechanism

GV Shurin, IL Tourkova, R Kaneno… - The Journal of …, 2009 - journals.aai.org
Antineoplastic chemotherapeutic agents may indirectly activate dendritic cells (DCs) by
inducing the release of “danger” signals from dying tumor cells. Whereas the direct cytotoxic …

[HTML][HTML] Cyanidin-3-rutinoside, a natural polyphenol antioxidant, selectively kills leukemic cells by induction of oxidative stress

R Feng, HM Ni, SY Wang, IL Tourkova… - Journal of Biological …, 2007 - ASBMB
Anthocyanins are a group of naturally occurring phenolic compounds widely available in
fruits and vegetables in human diets. They have broad biological activities including anti …

Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells …

GV Shurin, R Ferris, IL Tourkova, L Perez… - The Journal of …, 2005 - journals.aai.org
Breast and kidney-expressed chemokine (BRAK) CXCL14 is a new CXC chemokine with
unknown function and receptor selectivity. The majority of head and neck squamous cell …

Blocking antibody to the β-subunit of FSH prevents bone loss by inhibiting bone resorption and stimulating bone synthesis

LL Zhu, H Blair, J Cao, T Yuen, R Latif… - Proceedings of the …, 2012 - National Acad Sciences
Low estrogen levels undoubtedly underlie menopausal bone thinning. However, rapid and
profuse bone loss begins 3 y before the last menstrual period, when serum estrogen is …

ACTH protects against glucocorticoid-induced osteonecrosis of bone

M Zaidi, L Sun, LJ Robinson… - Proceedings of the …, 2010 - National Acad Sciences
We report that adrenocorticotropic hormone (ACTH) protects against osteonecrosis of the
femoral head induced by depot methylprednisolone acetate (depomedrol). This therapeutic …

[HTML][HTML] Chemomodulation of human dendritic cell function by antineoplastic agents in low noncytotoxic concentrations

R Kaneno, GV Shurin, IL Tourkova… - Journal of translational …, 2009 - Springer
The dose-delivery schedule of conventional chemotherapy, which determines its efficacy
and toxicity, is based on the maximum tolerated dose. This strategy has lead to cure and …

Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth

H Zhong, B Han, IL Tourkova, A Lokshin… - Clinical Cancer …, 2007 - AACR
Purpose: The main goal of this study was to provide the “proof-of-principle” that low-dose
paclitaxel is able to change the tumor microenvironment and improve the outcome of …

Estrogen inhibits RANKL-stimulated osteoclastic differentiation of human monocytes through estrogen and RANKL-regulated interaction of estrogen receptor-α with …

LJ Robinson, BB Yaroslavskiy, RD Griswold… - Experimental cell …, 2009 - Elsevier
The effects of estrogen on osteoclast survival and differentiation were studied using CD14-
selected mononuclear osteoclast precursors from peripheral blood. Estradiol at∼ 1 nM …

Inhibition of CD40 expression and CD40‐mediated dendritic cell function by tumor‐derived IL‐10

MR Shurin, ZR Yurkovetsky, IL Tourkova… - … Journal of Cancer, 2002 - Wiley Online Library
As CD40 plays a key role in both antitumor immunity and DC maturation, we have studied
the regulation of its expression during DC hematopoiesis (dendropoiesis) in vitro and in vivo …